Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jun 9, 2016 at 11:35 AM EDT

Tactile Systems Releases Tenative Pricing for IPO

Tactile Systems Technology expects to price 4 million shares within the range of $14 to $16 per share in an…

Chris Lange | Jun 9, 2016 at 9:40 AM EDT

Do Analysts See an Inflection Point in Valeant Pharmaceuticals After Earnings?

Despite its track record, some analysts are calling for an inflection point, while others are taking a relatively neutral stance…

Chris Lange | Jun 8, 2016 at 8:50 AM EDT

Flexion Therapeutics Raises More Capital in Secondary Offering

Shares of Flexion Therapeutics dropped early on Wednesday following the announcement of an underwritten public offering.

Chris Lange | Jun 7, 2016 at 11:25 AM EDT

Why the Zimmer Biomet and LDR Deal Is a Big Win

Shares of LDR skyrocketed in Tuesday's session following the definitive agreement for Zimmer Biomet to acquire the company for $1…

Chris Lange | Jun 7, 2016 at 11:10 AM EDT

Biogen Stumbles Over Missed Mid-Stage Results

Shares of Biogen slumped early in Tuesday's session following the release of less-than-favorable top-line results from its mid-stage clinical study…

Chris Lange | Jun 7, 2016 at 10:20 AM EDT

Why Earnings Were Not the Biggest Disappointment in Valeant’s Report

Valeant Pharmaceuticals International reported disappointing first-quarter financial results before the markets opened on Tuesday.

Jon C. Ogg | Jun 7, 2016 at 10:10 AM EDT

Why Analysts Are Still All Over the Place on Sarepta After FDA News

[cnxvideo id=”655243″ placement=”ros”]Sarepta Therapeutics Inc. (NASDAQ: SRPT) has seen more than its fair share of volatility in the market of…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

Chris Lange | Jun 6, 2016 at 11:40 AM EDT

The 5 Biggest Biotech and Pharma Losers From ASCO

Some call the ASCO annual meeting the "Super Bowl for biotechs" because of the significance it holds for so many…

Chris Lange | Jun 6, 2016 at 9:35 AM EDT

Why ProNAi Could Be the Biggest Loser at ASCO

The annual meeting for ASCO is generally one of the biggest weeks of the year for the health care sector.…

Lee Jackson | Jun 6, 2016 at 9:15 AM EDT

2 Analyst Biotech Stock Calls With Over 100% Upside Potential

The analysts at Wedbush focus in on two biotech companies that not only have data that could prove to be…

Chris Lange | Jun 6, 2016 at 8:55 AM EDT

Why Vascular Biogenics Is One of the Biggest Winners From ASCO So Far

As the annual meeting for the American Society of Clinical Oncology (ASCO) is underway, we are starting to see some…

Chris Lange | Jun 6, 2016 at 8:35 AM EDT

Why Ocular Therapeutix Is Sinking Despite Mixed Results

Ocular Therapeutix shares plunged early on Monday following less-than-favorable results, although the news was not all bad.

Jon C. Ogg | Jun 4, 2016 at 11:25 AM EDT

2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially

Many speculative calls are made on the biotech stocks. It is here that fortunes can easily be made. The dark…

Chris Lange | Jun 2, 2016 at 4:08 PM EDT

6 Biotechs Seriously on the Move

A few biotech companies made fantastic runs in Thursday’s session. We have included information about each company, as well as…

1 … 207 208 209 210 211 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Tactile Systems Releases Tenative Pricing for IPO

Do Analysts See an Inflection Point in Valeant Pharmaceuticals After Earnings?

Flexion Therapeutics Raises More Capital in Secondary Offering

Why the Zimmer Biomet and LDR Deal Is a Big Win

Biogen Stumbles Over Missed Mid-Stage Results

Why Earnings Were Not the Biggest Disappointment in Valeant’s Report

Why Analysts Are Still All Over the Place on Sarepta After FDA News

How Credit Suisse Views Major Pharma After ASCO

The 5 Biggest Biotech and Pharma Losers From ASCO

Why ProNAi Could Be the Biggest Loser at ASCO

2 Analyst Biotech Stock Calls With Over 100% Upside Potential

Why Vascular Biogenics Is One of the Biggest Winners From ASCO So Far

Why Ocular Therapeutix Is Sinking Despite Mixed Results

2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially

6 Biotechs Seriously on the Move

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Tactile Systems Releases Tenative Pricing for IPO

Do Analysts See an Inflection Point in Valeant Pharmaceuticals After Earnings?

Flexion Therapeutics Raises More Capital in Secondary Offering

Why the Zimmer Biomet and LDR Deal Is a Big Win

Biogen Stumbles Over Missed Mid-Stage Results

Why Earnings Were Not the Biggest Disappointment in Valeant’s Report

Why Analysts Are Still All Over the Place on Sarepta After FDA News

How Credit Suisse Views Major Pharma After ASCO

The 5 Biggest Biotech and Pharma Losers From ASCO

Why ProNAi Could Be the Biggest Loser at ASCO

2 Analyst Biotech Stock Calls With Over 100% Upside Potential

Why Vascular Biogenics Is One of the Biggest Winners From ASCO So Far

Why Ocular Therapeutix Is Sinking Despite Mixed Results

2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially

6 Biotechs Seriously on the Move

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check